EUVIMEDEUVIMED entdecken
Crossref

Assisted reproduction and the fetal malformation risk associated with antiseizure medication exposure in pregnancy

Frank Vajda iD, Terence O'Brien, Janet Graham iD, Alison Hitchcock iD, Piero Perucca iD, Cecilie Lander, Mervyn Eadie

Epilepsia · 2025-06 · 66 (6) · 1899-1906

DOI: 10.1111/epi.18335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 28.02.2025. Verfasst von Frank Vajda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Neurosciences, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Anticonvulsants, Reproductive Techniques, Assisted, Abnormalities, Drug-Induced, Epilepsy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Epilepsy Action Australia, UCB Pharma, Epilepsy Society of Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study was undertaken to explore the possible role of assisted reproduction treatment (ART) in the occurrence of fetal malformation in women with antiseizure medication (ASM)‐treated epilepsy.

Methods

Data collected in the Australian Pregnancy Register of Antiepileptic Drugs concerning the pregnancies of women with ASM‐treated epilepsy were analyzed using standard simple statistical methods.

Results

The malformed fetal occurrence rate tended to be higher in women with epilepsy (WWE) treated with ASMs than in those untreated in at least the earlier months of pregnancy, the risk being statistically significantly higher ( p < .05) in relation to valproate monotherapy. The malformation risk was greater when the pregnancy had been initiated via ART ( n = 152, malformation rate = 11.18%) than when ART was not involved ( n = 2388, malformation rate = 6.49%, relative risk [RR] = 1.72, 95% confidence interval [CI] = 1.07–2.77) and also greater versus ASM‐treated pregnancy not involving ART ( n = 2191, malformation rate = 6.79%, RR = 1.64, 95% CI = 1.02–2.64). The anatomical sites affected by the malformations also differed, the heart and great vessels being more often involved when ART had been involved. Multivariate logistic regression analysis suggested that the heightened malformation risk associated with ART plus ASM exposure seemed to be related to use of hormones in ART more than to in vitro fertilization. Significance WWE undertaking pregnancy through ART should be aware of the increased risk of fetal malformation beyond that related to ASM exposure. If this finding is supported in further studies, evaluations of fetal malformation risk rates associated with ASM exposure may need to be adjusted for possible overestimation because of confounder effects of ART, if ART was involved in the pregnancies studied.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsReproductive Techniques, AssistedAbnormalities, Drug-InducedEpilepsyPregnancy ComplicationsHumansFemalePregnancyAdultRegistriesRisk FactorsValproic AcidAustraliaYoung Adult

Stichwörter der Autor:innen

antiseizure medicationassisted reproduction techniquefetal malformationheart and great vesselsteratogenicity

Substanzen

AnticonvulsantsValproic Acid

Autor:innen und Institutionen

  • Department of Medicine and Neurosciences, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.
  • Department of Neuroscience, Monash University, Melbourne, Victoria, Australia.
  • Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.
  • Department of Medicine, Austin Health, University of Melbourne, Heidelberg, Victoria, Australia.
  • Bladin-Berkovic Comprehensive Epilepsy Program, Austin Health, Heidelberg, Victoria, Australia.
  • Royal Brisbane and Women's Hospital and School of Medicine and Biomedical Science, University of Queensland, Brisbane, Queensland, Australia.

ORCID-Profile: Frank Vajda, Janet Graham, Alison Hitchcock, Piero Perucca

Förderung

  • Epilepsy Action Australia
  • UCB Pharma
  • Epilepsy Society of Australia
  • Royal Melbourne Hospital Neuroscience Foundation
  • Eisai Incorporated
  • Sci-Gen
  • Jazz Pharmaceuticals
  • National Health and Medical Research Council

Zitieren

APA

Vajda, F., O'Brien, T., Graham, J., Hitchcock, A., Perucca, P., Lander, C., & Eadie, M. (2025). Assisted reproduction and the fetal malformation risk associated with antiseizure medication exposure in pregnancy. Epilepsia, 66(6), 1899-1906. https://doi.org/10.1111/epi.18335

Vancouver

Vajda F, O'Brien T, Graham J, Hitchcock A, Perucca P, Lander C, et al. Assisted reproduction and the fetal malformation risk associated with antiseizure medication exposure in pregnancy. Epilepsia. 2025;66(6):1899-1906. doi:10.1111/epi.18335

BibTeX
@article{Vajda2025,
  author = {Vajda, Frank and O'Brien, Terence and Graham, Janet and Hitchcock, Alison and Perucca, Piero and Lander, Cecilie and Eadie, Mervyn},
  title = {Assisted reproduction and the fetal malformation risk associated with antiseizure medication exposure in pregnancy},
  journal = {Epilepsia},
  year = {2025},
  volume = {66},
  number = {6},
  pages = {1899--1906},
  doi = {10.1111/epi.18335}
}
Kostenlos starten →